MainBiz Association’s ‘Innovator of the Month’ Interview: Wangje Won, Innovio Surge
- Innovio Surge, a south Korean company, is setting its sights on the U.S.
- The Main Biz Association, also known as the Korea Management Revolutionary Association, has named Innovio Surge as an innovative company of the month.This recognition is part of the...
- The dental implant market is known for its intense competition, with numerous domestic and international players vying for market share.Innovio Surge,despite being a relative newcomer,is aiming to stand...
Innovio Surge’s ‘IBS Implant’ Aims for US Market Success with Minimally Invasive Approach
Table of Contents
- Innovio Surge’s ‘IBS Implant’ Aims for US Market Success with Minimally Invasive Approach
- Main Biz Association Recognizes Innovio Surge
- A Crowded Market
- the ‘Uneven and minimal Invasive’ Advantage
- Comparing Procedures
- Overcoming Resistance to Change
- U.S. Market Strategy
- Focus on Quality Over Cost
- Patient Considerations
- About Wang Je-won
- Wang Je-won: A Pioneer in Implant Technology?
- Wang Je-won: A Pioneer in Implant Technology?
Innovio Surge, a south Korean company, is setting its sights on the U.S. dental implant market with its innovative ‘IBS Implant’ system. The company’s “uneven incess-minimum invasive implant treatment” has already garnered attention domestically, including recognition at the Small and Medium Business Technology Management Innovation Competition.
Main Biz Association Recognizes Innovio Surge
The Main Biz Association, also known as the Korea Management Revolutionary Association, has named Innovio Surge as an innovative company of the month.This recognition is part of the association’s ”Innovation Enterprise, Innovation Program,” launched last july to bolster management innovation and global competitiveness among South Korean SMEs, according to Chairman Kim Myung-jin.
A Crowded Market
The dental implant market is known for its intense competition, with numerous domestic and international players vying for market share.Innovio Surge,despite being a relative newcomer,is aiming to stand out with its unique approach.
the ‘Uneven and minimal Invasive’ Advantage
According to Innovio Surge’s representative, identified only as Wang, the key to the ‘IBS Implant’ system’s appeal lies in its product competitiveness. “The treatment paradigm is fully different from existing implants,” Wang stated. Unlike traditional methods that require cutting the gums to expose the jawbone, the ‘IBS Implant’ system allows for immediate implant placement without gum incisions, minimizing invasiveness.
Comparing Procedures
Wang explained that traditional implant procedures typically involve artificial muscles,abutments,and artificial teeth.These procedures often require cutting the gums and flattening the jawbone,leading to patient discomfort and a higher risk of gum inflammation.Bone grafts may also be necessary if the patient lacks sufficient jawbone density.
The ‘IBS Implant’ system, however, integrates the artificial root and abutment into a single structure that extends up to the gums. This integrated design reduces the need for extensive procedures, minimizing patient pain and the risk of gum inflammation.
Overcoming Resistance to Change
Wang acknowledged that some dentists might potentially be hesitant to adopt the new procedure due to the need to learn a new technique and potential compatibility issues with existing patients. Though,Wang draws parallels to the initial skepticism surrounding Per-Ingvar Brånemark’s titanium implant surgery,which is now widely recognized as a revolutionary advancement in dental implants.
Wang noted that Brånemark’s work, initially supported by the Swedish government, eventually gained widespread acceptance in the United States after demonstrating remarkable results in collaboration with the University of Toronto. Brånemark’s research showed a significant improvement in implant survival rates compared to previous methods. Wang hopes to replicate this success in the U.S. market with the ‘uneven-minimum invasive treatment’.
U.S. Market Strategy
Innovio Surge is shifting its strategy for entering the U.S. market. Instead of solely focusing on product sales, the company will prioritize educating american dentists about the ‘uneven-minimum invasive treatment’. The plan involves demonstrating the entire implant procedure process and cultivating a network of dentists in key areas such as Las Vegas, Los Angeles, San Diego, San Jose, Houston, and Sacramento.
The company intends to establish a centralized call centre to connect patients with dentists within its network.
Focus on Quality Over Cost
Wang explained that the decision to target the U.S. market stems from a desire to receive proper evaluation in a market that values quality.Wang expressed concern about the intense price competition in the South korean market, which can lead to compromised quality and potentially harm patients. Wang believes that patients should demand implant warranties to ensure the longevity of their implants.
Patient Considerations
Wang advises patients to carefully consider the product, surgical procedure, and dentist’s experience when choosing an implant. Avoiding excessively cheap options is crucial, as substandard procedures can lead to implant failure within a few years. Wang also emphasized the importance of addressing periodontal disease and ensuring proper occlusal adjustments after surgery.
About Wang Je-won
Wang Je-won graduated from Wonkwang University Dental College and graduate School. He served as CEO of Hyewon dental Clinic from 1992 to 2003 and has been the CEO of Innovio Surge since 2008.
Wang Je-won: A Pioneer in Implant Technology?
Wang Je-won’s development of the ‘IBS Implant’ has drawn comparisons to other pioneers in dental technology, such as Per-Ingvar Brånemark and Harold Kesling. Some consider Wang a potential game-changer in prosthetic treatment, similar to Brånemark’s introduction of titanium implants.
Wang’s interest in implants began with his own training course lead by a professor who studied in Sweden. Dissatisfied with the invasiveness of traditional procedures, Wang began researching minimally invasive techniques in 2003. This led to the development of the ‘IBS Implant’ and the founding of Innovio Surge in 2008.
To promote the ‘uneven-Minimal Invasion Procedure’,Wang published a book and established the AMII (Academy of Minimally Invasive Implantology) Training Institute. To date, over 1700 dentists have been trained in his procedure.
Lee Je-kyung of the 100th research Institute contributed to this report.
As CEO of Hyewon dental Clinic from 1992 to 2003 and has been the CEO of Innovio Surge since 2008.
Wang Je-won: A Pioneer in Implant Technology?
Wang Je-won’s progress of the ‘IBS implant’ has drawn comparisons to other pioneers in dental technology,such as Per-Ingvar Brånemark and Harold Kesling. Some consider Wang a potential game-changer in prosthetic treatment, similar to Brånemark’s introduction of titanium implants.
Wang’s interest in implants began with his own training course lead by a professor who studied in Sweden. Dissatisfied with the invasiveness of traditional procedures, Wang began researching minimally invasive techniques in 2003. This led to the development of the ‘IBS Implant’ and the founding of Innovio Surge in 2008.
To promote the ‘uneven-Minimal Invasion Procedure’,Wang published a book and established the AMII (Academy of Minimally Invasive Implantology) Training Institute.To date, over 1700 dentists have been trained in his procedure.
Lee Je-kyung of the 100th research Institute contributed to this report.
Q&A Blog Post: Innovio Surge’s ‘IBS Implant’
Introduction
Hello and welcome! Today, we’re diving deep into the world of dental implants, specifically focusing on Innovio Surge and its innovative ‘IBS Implant’ system. We’ll explore the tech, the market, and what it all means for patients and the future of dental care. Let’s get started with some frequently asked questions.
Q: What is the ‘IBS Implant’ and what makes it special?
A: The ‘IBS Implant’ is a dental implant system developed by Innovio Surge, a South Korean company. The key differentiator of the IBS Implant is its focus on a minimally invasive approach, which the company refers to as “uneven incess-minimum invasive implant treatment”.Unlike traditional methods that involve cutting the gums to expose the jawbone, the IBS system aims for immediate implant placement without incisions, which can potentially reduce patient discomfort and improve healing times. The design integrates the artificial root and abutment into a single structure that extends up to the gums,reducing the need for extensive procedures.
Q: How does the ‘IBS Implant’ procedure compare to traditional dental implant procedures?
A: traditional implant procedures typically involve several steps: cutting the gums, flattening the jawbone if needed, and often requiring bone grafts. Different components includes artificial muscles, abutments, and artificial teeth will be needed to be integrated into the jawbone. These more invasive procedures can cause more discomfort and lead to a higher risk of gum inflammation. The ‘IBS Implant’, on the other hand, aims to streamline this process. By integrating the post and abutment into a single structure, the ‘IBS Implant’ procedure tries to reduce the need for extensive cutting and manipulation, leading to potentially less pain, fewer complications, and, in theory, a faster recovery.
Q: What are the potential benefits of the ‘uneven-minimum invasive treatment’ for patients?
A: The approach offers several potential advantages:
less Pain and Discomfort: Minimizing incisions can lead to a less painful experience during and after the procedure.
Reduced Gum Inflammation: Reducing the invasiveness could minimize the risk of inflammation and related complications.
faster Recovery: By reducing the trauma to the tissues, the IBS Implant could potentially expedite the healing process.
Potentially fewer bone grafting procedures:
Streamlined Implantation process.
Q: I’ve heard about the company innovio Surge – what recognition has it received?
A: Innovio Surge has gained recognition for its innovative approach. The company was named an innovative company of the month by the main Biz Association, also known as the Korea Management Revolutionary Association. The company has also been recognized at the Small and Medium Business Technology Management Innovation Competition.
Q: What is Innovio Surge’s U.S. market strategy?
A: Innovio Surge is taking a strategic approach to enter the competitive U.S. dental implant market. Instead of solely focusing on direct product sales, the company plans to prioritize educating American dentists about the ‘uneven-minimum invasive treatment’. Their plan involves:
demonstrating the entire implant procedure process to dentists in key areas.
Cultivating a network of dentists in key locations such as Las Vegas, Los Angeles, San Diego, San Jose, Houston, and Sacramento.
Establishing a centralized call centre to connect patients with dentists in their network.
Q: What does Innovio Surge’s interest in establishing a network imply?
A: Innovio Surge also aims to increase its recognition by establishing a network of dentists, which is very similar to how the titanium implants were implemented decades previously.Dentists will need to be well-versed in the IBS method to implement the technology and Innovio Surge is establishing a method to do just that.
Q: Wang je-won, the CEO of Innovio Surge, has a long history.Can you tell me about him?
A: Absolutely! Wang Je-won is the CEO of Innovio Surge, a position he has held since 2008. Before that,he graduated from Wonkwang University Dental College and Graduate School. He served as the CEO of Hyewon Dental Clinic from 1992 to 2003. His extensive experience in the dental field helps him understand the needs of the industry and spearheads the direction Innovio Surge.
Q: Why is Innovio Surge targeting the U.S. market, and what’s their focus on quality over cost?
A: wang Je-won, the head of Innovio Surge, made a strategic decision to prioritize the U.S. market due to the high value placed on quality within that environment. This is a marked contrast to the South Korean market, were intense price competition could potentially lead to compromises in quality. Wang believes that patients should demand implant warranties to ensure the durability and longevity of their implants. This demonstrates a strong commitment to patient well-being and long-term dental health.
Q: what should patients consider when choosing a dental implant?
A: Wang je-won provides sound advice. When selecting a dental implant, patients should carefully assess several key factors:
Product Quality: Evaluate the quality of the implant system itself.
Surgical Procedure: Understand the invasiveness and techniques used in the procedure.
Dentist’s Experience: Choose a dentist with ample experience and expertise in implant procedures.
Price: Be wary of extremely cheap offers, as substandard procedures can lead to implant failure in a few years.
Q: What is the Academy of Minimally Invasive Implantology?
A: To promote the ‘uneven-Minimal Invasion procedure’, Wang published a book and established the AMII (academy of Minimally Invasive Implantology) Training Institute. Wang has trained over 1700 dentists in the proper procedure and method utilizing the IBS Implant.
Q: From a patient perspective, What is important to consider?
A: It’s crucial for patients to consider the product, the surgical procedure involved, and the experience of the dentist. Avoiding low-cost options is a key element of implant longevity; more importantly, it’s important to assess for any potential underlying issues. Wang also emphasizes the importance of addressing any existing periodontal disease and making necessary occlusal adjustments after the surgery.
Conclusion
The ‘IBS Implant’ system offers a potentially innovative approach to dental implants, and the success of Innovio Surge in the U.S. market will be an exciting development to watch. It’s important to remember that every patient’s situation is unique, and consulting with a qualified and experienced dental professional is essential for determining the most appropriate treatment plan.